Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
GlaxoSmithKline |
---|---|
Information provided by: | GlaxoSmithKline |
ClinicalTrials.gov Identifier: | NCT00400335 |
The combination of testosterone and dutasteride is intended for use in hypogonadal men. This study will evaluate the bioavailability and pharmacokinetics of various doses of testosterone administered with and without dutasteride
Condition | Intervention | Phase |
---|---|---|
Hypogonadism |
Drug: Nanomilled testosterone Drug: commercially available dutasteride Drug: Nanomilled dutasteride |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Parallel Assignment, Pharmacokinetics/Dynamics Study |
Official Title: | An Open Label Study to Evaluate the Impact of Novel Fixed-Dose Testosterone/Dutasteride Combinations on the Relative Bioavailability of the Individual Dutasteride and Testosterone Components |
Enrollment: | 60 |
Study Start Date: | October 2006 |
Ages Eligible for Study: | 18 Years to 50 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion criteria:
Exclusion criteria:
United States, Washington | |
GSK Investigational Site | |
Tacoma, Washington, United States, 98418 |
Study Director: | GSK Clinical Trials, M.D., Ph.D., FACP | GlaxoSmithKline |
Responsible Party: | GSK ( Study Director ) |
Study ID Numbers: | TDC106222 |
Study First Received: | November 14, 2006 |
Last Updated: | October 9, 2008 |
ClinicalTrials.gov Identifier: | NCT00400335 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Hypogonadism Testosterone Dutasteride |
DHT Androgen deficiency Men |
Antineoplastic Agents, Hormonal Gonadal Disorders Hormone Antagonists Hormones, Hormone Substitutes, and Hormone Antagonists Endocrine System Diseases Methyltestosterone Hormones |
Testosterone 17 beta-cypionate Dutasteride Anabolic Agents Testosterone Hypogonadism Endocrinopathy Androgens |
Molecular Mechanisms of Pharmacological Action Antineoplastic Agents, Hormonal Antineoplastic Agents Gonadal Disorders Physiological Effects of Drugs Hormones, Hormone Substitutes, and Hormone Antagonists Endocrine System Diseases Enzyme Inhibitors Methyltestosterone |
Hormones Pharmacologic Actions Testosterone 17 beta-cypionate Dutasteride Anabolic Agents Testosterone Hypogonadism Therapeutic Uses Androgens |